Scroll to top

Scroll to top

News Releases

Home
Investors
News Releases

News Releases

Month Year

Month Year

Investor Alerts

November 13, 2025

Immunic, Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update
October 29, 2025

Immunic to Participate in Industry and Investor Conferences in November
October 1, 2025

Immunic to Participate in Scientific and Investor Conferences in October
September 25, 2025

Immunic Presented Key Vidofludimus Calcium Data at the 41st Congress of ECTRIMS, Highlighting Its Potential in Multiple Sclerosis
September 9, 2025

Immunic Receives Notice of Allowance for United States Patent Protecting Vidofludimus Calcium's Dose Strengths in Progressive Multiple Sclerosis

Show per page